Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Applied Therapeutics IncCOMM | 5,374,982 | 6,111,906 | +736,924 | $18.01M | $41.56M | 24.19% | +$23.55M |
| Plains Gp Holdings Lp-ClCOMM ENHANCED INM ETF | 120,221 | 1,492,581 | +1,372,360 | $2.95M | $27.98M | 16.29% | +$25.03M |
| TScan Therapeutics, Inc.COMM(TCRX) | 2,087,139 | 2,087,139 | 0 | $12.17M | $16.57M | 9.65% | +$4.40M |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 30,032 | 43,032 | +13,000 | $6.95M | $11.49M | 6.69% | +$4.54M |
| Achieve Life Sciences IncCOMM | 0 | 2,453,092 | +2,453,092 | $0 | $11.15M | 6.49% | +$11.15M |
| Phathom Pharmaceuticals, Inc.COMM(PHAT) | 443,047 | 869,927 | +426,880 | $4.05M | $9.24M | 5.38% | +$5.19M |
| Akero Therapeutics IncCOMM | 100,052 | 327,752 | +227,700 | $2.34M | $8.28M | 4.82% | +$5.94M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 750,000 | 750,000 | 0 | $5.06M | $7.08M | 4.12% | +$2.02M |
| Avidity Biosciences IncCOMM | 178,500 | 178,500 | 0 | $1.62M | $4.56M | 2.65% | +$2.94M |
| Day One Biopharmaceuticals ICOMM COM | 270,664 | 270,664 | 0 | $3.95M | $4.47M | 2.60% | +$519.7K |
| Ardelyx IncCOMM | 594,174 | 594,174 | 0 | $3.68M | $4.34M | 2.52% | +$653.6K |
| Athira Pharma IncCOMM | 1,492,792 | 1,492,792 | 0 | $3.63M | $4.09M | 2.38% | +$462.8K |
| Kura Oncology, Inc.COMM(KURA) | 130,000 | 130,000 | 0 | $1.87M | $2.77M | 1.61% | +$903.5K |
| Telesat CorporationCOMM(TSAT) | 290,781 | 290,781 | 0 | $3.03M | $2.50M | 1.46% | -$532.1K |
| Kymera Therapeutics, Inc.COMM(KYMR) | 56,359 | 56,359 | 0 | $1.43M | $2.27M | 1.32% | +$830.7K |
| Ishares Mbs EtfCOMM | 22,400 | 22,400 | 0 | $2.11M | $2.07M | 1.20% | -$37.2K |
| Syndax Pharmaceuticals, Inc.COMM(SNDX) | 0 | 83,259 | +83,259 | $0 | $1.98M | 1.15% | +$1.98M |
| Mirum Pharmaceuticals, Inc.COMM(MIRM) | 70,000 | 70,000 | 0 | $2.07M | $1.76M | 1.02% | -$308.0K |
| Marinus Pharmaceuticals IncCOMM | 180,100 | 180,100 | 0 | $1.96M | $1.63M | 0.95% | -$329.6K |
| Kayne Anderson Energy Infrastructure Fund, Inc.COMM(KYN) | 147,033 | 147,033 | 0 | $1.29M | $1.47M | 0.86% | +$180.8K |
| Sutro Biopharma, Inc.COMM(STRO) | 195,000 | 195,000 | 0 | $836.5K | $1.10M | 0.64% | +$265.2K |
| Trevi Therapeutics, Inc.COMM(TRVI) | 0 | 260,000 | +260,000 | $0 | $897.0K | 0.52% | +$897.0K |
| X4 Pharmaceuticals, Inc.COMM(XFOR) | 535,000 | 535,000 | 0 | $448.6K | $743.6K | 0.43% | +$295.1K |
| Eiger Biopharmaceuticals IncCOMM | 0 | 146,381 | +146,381 | $0 | $731.9K | 0.43% | +$731.9K |
| Ishares Iboxx InvestmentCOMM | 4,456 | 4,456 | 0 | $493.1K | $485.3K | 0.28% | -$7.8K |
| Cybin D/B/A Helus PharmaCOMM(HELP) | 850,000 | 850,000 | 0 | $348.5K | $351.5K | 0.20% | +$3.0K |
| Fidelity Inv Mmtrsy 1 680COMM | 4,772,389 | 211,541 | -4,560,848 | $4.77M | $211.5K | 0.12% | -$4.56M |
| Chinook Therapeutics Inc CvrCOMM | 79,357 | 79,357 | 0 | $0 | $30.9K | 0.02% | +$30.9K |
| Agios Pharmaceuticals, Inc.COMM(AGIO) | 5,792 | 0 | -5,792 | $129.0K | $0 | — | -$129.0K |
| Crinetics Pharmaceuticals InCOMM | 165,000 | 0 | -165,000 | $5.87M | $0 | — | -$5.87M |
| Eiger Biopharmaceuticals IncCOMM | 4,391,432 | 0 | -4,391,432 | $985.9K | $0 | — | -$985.9K |
| Heron Therapeutics, Inc.COMM(HRTX) | 104,195 | 0 | -104,195 | $177.1K | $0 | — | -$177.1K |
| Ishares 0-5 Yr Inv Grd CoCOMM 0-5YR INVT GR CP | 12,148 | 0 | -12,148 | $597.7K | $0 | — | -$597.7K |
| Ishares Ibonds Dec 2024 TCOMM | 85,442 | 0 | -85,442 | $2.13M | $0 | — | -$2.13M |
| Plains GP Holdings, L.P.COMM(PAGP) | 1,372,360 | 0 | -1,372,360 | $21.89M | $0 | — | -$21.89M |
| Spdr Bloomberg InvestmentCOMM ST STR RATE ETF | 9,267 | 0 | -9,267 | $283.5K | $0 | — | -$283.5K |
| Spdr Port Shrt Trm Corp BCOMM ST SHOR CORP ETF | 45,695 | 0 | -45,695 | $1.36M | $0 | — | -$1.36M |
| Vanguard Short-Term BondCOMM | 27,712 | 0 | -27,712 | $2.13M | $0 | — | -$2.13M |